Recently, Jiangxi Fushine Biotechnology Co., Ltd., a wholly-owned subsidiary of Fushine Pharmaceuticals, received the government's "Notice on Issuing Enterprise Development Support Funds" and is expected to receive a government subsidy of 35.4 million yuan.

As an emerging field, synthetic biology has become a key area of international economic competition, poised to ignite a biotechnology revolution and attracting widespread attention from government, academia, and the financial sector. Fushine Bio's award of this grant, based on its breakthrough progress in synthetic microbial proteins, is a testament to the government's strong support and deep expectations for the field.

Fushine Bio

Fushine Biotechnology is a company specializing in the development of biofermentation technology, production, and sales of biofermentation products. It is an important exploration and practice of Fushine Pharmaceuticals in the field of biosynthesis. Covering an area of approximately 200,000 square meters, Fushine Biotechnology designs and constructs a biofermentation microbial protein production line in accordance with high-standard, fully automated concepts. It utilizes its fermented yeast liquid through refining, concentration, and compounding methods to produce amino acid water-soluble fertilizers, achieving recycling in the production process and striving for zero emissions! As of now, Fushine's annual microbial protein production capacity is 1,200 tons. A 20,000-ton microbial protein workshop and a 50,000-ton amino acid water-soluble fertilizer workshop are under construction. In the future, the facility will be expanded to a 200,000-ton workshop, breaking the domestic production capacity record for similar factories!

Announcement text